Cannabis: Complete Guide to Effects, Dosage & Safe Use
The most widely used psychoactive botanical worldwide, containing cannabinoids and terpenes that interact with the endocannabinoid system.
Quick Reference
- Onset
- 5-15 min (inhaled), 30-90 min (oral)
- Duration
- 1-3 hours (inhaled), 4-8 hours (oral)
- Intensity
- Mild-strong (dose/strain dependent)
- Legal status
- Legal (US)
- Evidence level
- Research-backed
What it is
Cannabis has been cultivated for over 5,000 years, originally in Central Asia for fiber, food, and medicine before spreading globally through trade routes [1]. The plant contains over 100 cannabinoids and 150 terpenes that work synergistically through what researchers call the "entourage effect" — where compounds enhance or modify each other's activity [2].
Today, cannabis is widely used for various wellness purposes, and research into its properties continues to expand, and recreationally for its mood-altering properties. The cannabinoid profile varies dramatically between cultivars: high-THC varieties produce the characteristic psychoactive effects, while CBD-dominant strains offer therapeutic benefits with minimal intoxication. Modern breeding has created specialized chemovars optimized for specific ratios of cannabinoids and terpenes.
What makes cannabis unique among botanicals is its direct interaction with the endocannabinoid system — a regulatory network discovered only in the 1990s that modulates everything from pain perception to mood [3]. This explains cannabis's remarkably broad therapeutic profile and why it affects users so differently based on their individual endocannabinoid tone.
Effects
Cannabis effects follow predictable patterns based on cannabinoid ratios and consumption method. THC-dominant varieties typically produce euphoria, altered time perception, and sensory enhancement within 5-15 minutes of inhalation. Users report feeling "lifted" mentally while physically relaxed, with peak effects lasting 1-2 hours before gradually tapering.
Oral consumption creates a markedly different experience. Edibles take 30-90 minutes to onset as THC converts to 11-hydroxy-THC in the liver — a more potent metabolite that produces stronger body effects and can last 6-8 hours [4]. The delayed onset catches many users off-guard, leading to overconsumption.
CBD-rich varieties feel entirely different: users describe clear-headed relaxation, reduced anxiety, and pain relief without intoxication. High-CBD cannabis often produces a subtle sense of well-being that many don't initially notice until the effects wear off. Balanced THC:CBD ratios (1:1 or 2:1) offer mild psychoactivity with reduced anxiety — what many consider the "sweet spot" for wellness use.
Terpenes significantly modify these base effects. Myrcene-heavy indicas tend toward sedation, while limonene and pinene-rich sativas promote alertness and focus [5]. The same THC percentage can feel energizing or sleepy depending on the terpene profile.
The Science
Cannabis works through the endocannabinoid system, a network of CB1 and CB2 receptors throughout the brain and body that regulate homeostasis [6]. THC directly binds CB1 receptors concentrated in areas controlling memory, coordination, pleasure, and time perception — explaining its characteristic effects. CBD doesn't directly bind these receptors but modulates their activity, often dampening THC's more intense effects [7].
The system uses endogenous cannabinoids like anandamide and 2-AG that our bodies naturally produce. External cannabinoids from cannabis essentially hijack this system, which explains both therapeutic benefits and potential for dependence. CB2 receptors, found mainly in immune tissues, help explain cannabis's anti-inflammatory effects.
Recent research has identified additional mechanisms beyond classical cannabinoid receptors. CBD interacts with serotonin 5-HT1A receptors (explaining anxiolytic effects) and TRPV1 channels (contributing to pain relief) [8]. Terpenes like caryophyllene uniquely bind CB2 receptors directly, while others like myrcene enhance THC's ability to cross the blood-brain barrier [9].
Chronic use leads to CB1 receptor downregulation, requiring higher doses for the same effects — the neurobiological basis of tolerance [10]. This adaptation reverses within 2-4 weeks of abstinence, explaining why tolerance breaks are effective.
Dosage
Dosing cannabis requires understanding both THC content and personal tolerance. For flower, we recommend starting with 0.25-0.5 grams (roughly a small bowl) of 15-20% THC cannabis for new users. Experienced users typically consume 0.5-2 grams per session depending on tolerance and desired intensity.
Edibles follow different guidelines due to hepatic metabolism. First-time users should start with 2.5mg THC and wait two full hours before additional dosing [11]. Therapeutic users often find their sweet spot between 5-10mg, while regular users may require 20-50mg. We've seen experienced users consume 100mg+ doses, though this increases adverse effect risk.
CBD dosing follows a bell curve — more isn't always better. Research suggests 15-25mg CBD provides optimal anxiolytic effects, while pain relief often requires 25-50mg doses [12]. Higher doses (100mg+) may actually be less effective due to CBD's biphasic response curve.
Vaporizing offers the most precise dosing control since effects appear within minutes. Start with 1-2 small draws, wait 15 minutes, then adjust accordingly. Concentrates require extreme caution — a rice grain-sized dab (0.05-0.1g) of 70-80% THC extract equals roughly 35-80mg THC, equivalent to a very strong edible dose delivered instantly.
Forms & How to Use
Flower remains the most popular form, offering full-spectrum effects and immediate onset control. Quality indicators include trichome coverage (visible crystals), strong terpene aroma, and proper cure — avoid harsh, hay-smelling cannabis or overly dry buds that crumble to dust. Store in airtight containers with humidity packs to maintain 58-62% relative humidity.
Concentrates like shatter, wax, and live resin contain 60-90% cannabinoids, requiring specialized equipment and extreme dose awareness. Live resin preserves more terpenes than other extraction methods, providing effects closer to flower. Rosin, made without solvents, is preferred by health-conscious users though typically costs more.
Edibles offer precise dosing and discrete consumption but require patience due to delayed onset. Gummies and chocolates provide consistent dosing, while homemade edibles can have hot spots of uneven THC distribution. We recommend commercial products with lab testing for accurate dosing, especially for new users.
Tinctures placed under the tongue (sublingual) onset within 15-30 minutes — faster than edibles but slower than inhalation. This method allows dose titration while avoiding lung irritation. Quality tinctures use CO2 or ethanol extraction and provide clear cannabinoid ratios on the label.
Vaporizers heat cannabis to 350-410°F, releasing cannabinoids without combustion byproducts. Lower temperatures (350-375°F) emphasize terpenes and provide more cerebral effects, while higher temperatures (390-410°F) release more cannabinoids for stronger body effects [13].
Safety
Cannabis interacts with several medication classes through cytochrome P450 enzymes, particularly CYP3A4 and CYP2C9 [14]. CBD significantly inhibits these enzymes, potentially increasing levels of blood thinners like warfarin, seizure medications, and some heart medications. THC can enhance sedative effects of alcohol, benzodiazepines, and opioids — combinations that increase accident risk.
While cannabis doesn't cause fatal overdoses, acute intoxication can produce anxiety, paranoia, and impaired coordination lasting several hours. Signs of overconsumption include rapid heartbeat, sweating, nausea, and panic attacks. These effects are temporary but unpleasant — the reason we emphasize conservative dosing.
Regular use can lead to Cannabis Use Disorder, affecting approximately 9% of users [15]. Warning signs include inability to reduce use despite negative consequences, tolerance requiring higher doses, and withdrawal symptoms like irritability, sleep problems, and reduced appetite when stopping. Unlike alcohol or substance discontinuation support, cannabis withdrawal isn't dangerous but can be uncomfortable.
Pregnant and breastfeeding individuals should avoid cannabis, as THC crosses the placenta and appears in breast milk. Adolescents face higher addiction risk and potential impacts on brain development, particularly with high-THC products [16]. People with personal or family history of psychosis should exercise extreme caution, as cannabis can precipitate psychiatric episodes in vulnerable individuals.
Driving impairment begins immediately after use and can last 3-6 hours depending on dose and tolerance. Unlike alcohol, no reliable roadside tests exist for cannabis impairment, making personal responsibility crucial.
Health Disclaimer: This information is for educational purposes only and is not medical advice. Consult a qualified healthcare provider before using any substance, especially if you take medications or have a medical condition.
Legal Status
An interactive legal status map will appear here. Check legality by state and country.
Trusted Vendors
Vendor listings coming soon. We vet every vendor for third-party testing, GMP compliance, and transparent sourcing.
Sources & Citations
- [1]Russo, E.B.. “History of Cannabis and Its Preparations in Saga, Science, and Sobriquet” Chemistry & Biodiversity, 2007. DOI: 10.1002/cbdv.200790144 [Link]
- [2]Russo, E.B.. “Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects” British Journal of Pharmacology, 2011. DOI: 10.1111/j.1476-5381.2011.01238.x [Link]
- [3]Lu, H.C. & Mackie, K.. “An Introduction to the Endogenous Cannabinoid System” Biological Psychiatry, 2016. DOI: 10.1016/j.biopsych.2015.07.028 [Link]
- [4]Grotenhermen, F.. “Pharmacokinetics and pharmacodynamics of cannabinoids” Clinical Pharmacokinetics, 2003. DOI: 10.2165/00003088-200342160-00003 [Link]
- [5]Sommano, S.R. et al.. “The Cannabis Terpenes” Molecules, 2020. DOI: 10.3390/molecules25245792 [Link]
- [6]Howlett, A.C. et al.. “International Union of Pharmacology. XXVII. Classification of cannabinoid receptors” Pharmacological Reviews, 2002. DOI: 10.1124/pr.54.2.161 [Link]
- [7]Laprairie, R.B. et al.. “Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor” British Journal of Pharmacology, 2015. DOI: 10.1111/bph.13250 [Link]
- [8]Blessing, E.M. et al.. “Cannabidiol as a Potential Treatment for Anxiety Disorders” Neurotherapeutics, 2015. DOI: 10.1007/s13311-015-0387-1 [Link]
- [9]Booth, J.K. & Bohlmann, J.. “Terpenes in Cannabis sativa – From plant genome to humans” Plant Science, 2019. DOI: 10.1016/j.plantsci.2019.03.022 [Link]
- [10]Hirvonen, J. et al.. “Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers” Molecular Psychiatry, 2012. DOI: 10.1038/mp.2011.82 [Link]
- [11]MacCallum, C.A. & Russo, E.B.. “Practical considerations in medical cannabis administration and dosing” European Journal of Internal Medicine, 2018. DOI: 10.1016/j.ejim.2018.01.004 [Link]
- [12]Millar, S.A. et al.. “A systematic review on the pharmacokinetics of cannabidiol in humans” Frontiers in Pharmacology, 2018. DOI: 10.3389/fphar.2018.01365 [Link]
- [13]Lanz, C. et al.. “Medicinal Cannabis: In Vitro Validation of Vaporizers for the Smoke-Free Inhalation of Cannabis” PLoS One, 2016. DOI: 10.1371/journal.pone.0147286 [Link]
- [14]Yamaori, S. et al.. “Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes” Biochemical Pharmacology, 2012. DOI: 10.1016/j.bcp.2012.07.006 [Link]
- [15]Hasin, D.S. et al.. “Cannabis use disorder in the U.S.: Prevalence, correlates, comorbidity, and criteria validity” Psychological Medicine, 2020. DOI: 10.1017/S0033291719003295 [Link]
- [16]Volkow, N.D. et al.. “Adverse health effects of marijuana use” New England Journal of Medicine, 2014. DOI: 10.1056/NEJMra1402309 [Link]